title: Fovea-sparing internal limiting membrane peeling for myopic traction maculopathy.
abstract: OBJECTIVE
  To investigate the effectiveness and safety of a new surgical technique of fovea-sparing internal limiting membrane (ILM) peeling for the treatment of foveal retinal detachments (RDs) in eyes with myopic traction maculopathy.
  
  
  METHODS
  Retrospective, consecutive, interventional case series.
  
  
  METHODS
  Forty-five eyes of 45 consecutive patients who underwent vitrectomy and ILM peeling for the treatment of a foveal RD attributable to myopic traction maculopathy were studied. The patients were divided into 2 groups by the area of ILM peeled: complete macular ILM peeled group (30 eyes) and fovea-sparing ILM peeled group (15 eyes). A gas tamponade was used in all of the eyes. The main outcome measures were the rate of development of a full-thickness macular hole (MH) and the best-corrected visual acuity (BCVA). All of the patients were followed for more than 6 months.
  
  
  RESULTS
  A full-thickness MH developed in 5 of 30 eyes (16.7%) in the complete ILM peeled group and in none of the 15 eyes in the fovea-sparing ILM peeled group. Postoperative OCT examination showed a contraction of the residual ILM on the fovea and reduction of the outer lamellar holes in the fovea-sparing ILM peeled group. The postoperative BCVA was significantly better than the preoperative BCVA in the fovea-sparing ILM peeled group (P = .04), but not in the complete ILM peeled group.
  
  
  CONCLUSIONS
  Fovea-sparing ILM peeling results in better visual and anatomic outcomes for the treatment of foveal RD attributable to myopic traction maculopathy. These were accomplished by reducing the development of a full-thickness MH.
authors: Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Japan.
authors: Noriaki
authors: N
authors: Shimada
authors: Yoshiharu
authors: Y
authors: Sugamoto
authors: Manabu
authors: M
authors: Ogawa
authors: Hiroshi
authors: H
authors: Takase
authors: Kyoko
authors: K
authors: Ohno-Matsui
mesh_terms: D000328:Adult; D000368:Aged; D001485:Basement Membrane / Q000473:pathology / Q000601:surgery*; D004396:Coloring Agents; D058450:Endotamponade; D005260:Female; D006801:Humans; D007208:Indocyanine Green; D008297:Male; D008875:Middle Aged; D047728:Myopia, Degenerative / Q000150:complications / Q000503:physiopathology / Q000601:surgery*; D011183:Postoperative Complications; D016684:Prone Position; D012163:Retinal Detachment / Q000209:etiology / Q000503:physiopathology / Q000601:surgery*; D012167:Retinal Perforations / Q000209:etiology; D012189:Retrospective Studies; D013194:Staining and Labeling; D013459:Sulfur Hexafluoride / Q000008:administration & dosage*; D016896:Treatment Outcome; D014792:Visual Acuity / Q000502:physiology; D014821:Vitrectomy
chemical_list: D004396:Coloring Agents; D007208:Indocyanine Green; D013459:Sulfur Hexafluoride